Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-05-19 to 2025-06-18
Current total value of award: $432.78
Description: 8511386927!HEPATITIS A VIRUS V